Safety of outpatient treatment in acute pulmonary embolism

医学 肺栓塞 回顾性队列研究 队列 低分子肝素 门诊部 内科学 儿科 外科 肝素
作者
Petra Erkens,Esteban Gándara,Peter Verhamme,Alex Yi-Hao Shen,Gauruv Bose,Grégoire Le Gal,Marc Rodger,Martin H. Prins,Marc Rodger
出处
期刊:Journal of Thrombosis and Haemostasis [Elsevier BV]
卷期号:8 (11): 2412-2417 被引量:98
标识
DOI:10.1111/j.1538-7836.2010.04041.x
摘要

Data regarding outpatient treatment of pulmonary embolism (PE) is scarce. This study evaluates the safety of outpatient management of acute PE.This is a retrospective cohort study of consecutive patients presenting at the Ottawa Hospital with acute PE diagnosed between 1 January 2007 and 31 December 2008. PE was defined as an arterial filling defect on CTPA or a high probability V/Q scan. Patients were managed as outpatients if they were hemodynamically stable, did not require supplemental oxygenation and did not have contraindications to low-molecular-weight heparin therapy.In this cohort of 473 patients with acute PE, 260 (55.0%) were treated as outpatients and 213 (45.0%) were admitted to the hospital. The majority of the patients were admitted because of severe comorbidities (45.5%) or hypoxia (22.1%). No outpatient died of fatal PE during the 3-month follow-up period. At the end of follow-up, the overall mortality was 5.0% (95% CI, 2.7-8.4%). The rates of recurrent venous thromboembolism (VTE) in outpatients were 0.4% (95% CI, 0.0-2.1%) and 3.8% (95% CI, 1.9-7.0%) within 14 days and 3 months, respectively. The rates of major bleeding episodes were 0% (95% CI, 0-1.4%) and 1.5% (95% CI, 0.4-3.9%) within 14 days and 3 months, respectively. Four (1.5%) outpatients were admitted to the hospital within 14 days.A majority of patients with acute PE can be managed as outpatients with a low risk of mortality, recurrent VTE and major bleeding episodes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qing发布了新的文献求助10
2秒前
隐形曼青应助Tracy采纳,获得10
3秒前
5秒前
5秒前
不安的成协完成签到,获得积分10
5秒前
噜噜噜完成签到,获得积分10
5秒前
7秒前
自然醒应助风云鱼采纳,获得10
8秒前
8秒前
shenmin发布了新的文献求助10
8秒前
9秒前
地球发布了新的文献求助10
10秒前
Kashing发布了新的文献求助20
11秒前
自然醒应助静默采纳,获得10
11秒前
11秒前
13秒前
蛋黄酥完成签到,获得积分20
13秒前
13秒前
14秒前
地球发布了新的文献求助10
14秒前
烟花应助kkkkkkk采纳,获得10
15秒前
15秒前
16秒前
16秒前
cc发布了新的文献求助10
17秒前
地球发布了新的文献求助10
18秒前
18秒前
NexusExplorer应助zjcomposite采纳,获得10
18秒前
18秒前
147发布了新的文献求助10
19秒前
21秒前
氨气发布了新的文献求助10
21秒前
22秒前
Khalifa完成签到,获得积分10
22秒前
123完成签到,获得积分10
22秒前
Tracy完成签到,获得积分10
23秒前
丘比特应助sss采纳,获得10
24秒前
24秒前
25秒前
地球发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6517235
求助须知:如何正确求助?哪些是违规求助? 8310298
关于积分的说明 17764830
捐赠科研通 5619592
什么是DOI,文献DOI怎么找? 2925899
邀请新用户注册赠送积分活动 1902725
关于科研通互助平台的介绍 1763767